Quarterly Result13 Feb 2026, 06:33 pm
Biofil Chemicals & Pharmaceuticals Ltd. Announces Q3 and Nine Months Financial Results for 2025
AI Summary
Biofil Chemicals & Pharmaceuticals Ltd. announced the financial results for the quarter and nine months ended on 31st December 2025. The un-audited standalone financial results were approved in a Board Meeting on 13th February 2026. The company's revenue from operations stands at 3,340.22 Lakhs for the quarter and 2,505.12 Lakhs for the nine months period.
Key Highlights
- Un-audited financial results for Q3 and nine months ended on 31st December 2025 approved in the Board Meeting.
- Revenue from operations for the quarter is 3,340.22 Lakhs and 2,505.12 Lakhs for the nine months period.
- The financial results are prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and other accounting principles generally accepted in India.
Price Impact
More from BIOFILCHEM